X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-13 | COLL | Smith Thomas B | EVP, Chief Medical Officer | S - Sale | $36.62 | -9,593 | 53,816 | -15% | -$351,320 | ||||||
| M | 2024-09-05 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $38.26 | -20,225 | 119,184 | -15% | -$773,792 | |||||
2024-06-03 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $32.57 | -25,000 | 139,409 | -15% | -$814,180 | ||||||
2024-05-28 | COLL | Tupper Colleen | EVP, CFO | S - Sale | $34.21 | -19,710 | 130,845 | -13% | -$674,368 | ||||||
| DM | 2024-05-23 | COLL | Dreyer Scott | EVP, Chief Commercial Officer | S - Sale+OE | $33.91 | -108,016 | 105,902 | -50% | -$3,662,548 | |||||
| D | 2024-05-14 | COLL | Bohlin Garen G | Dir | S - Sale+OE | $32.30 | -28,985 | 52,468 | -36% | -$936,311 | |||||
2024-02-29 | COLL | Smith Thomas B | EVP, Chief Medical Officer | S - Sale | $36.76 | -995 | 63,409 | -2% | -$36,580 | ||||||
2024-02-26 | COLL | Dreyer Scott | EVP, Chief Commercial Officer | S - Sale | $36.43 | -10,000 | 138,918 | -7% | -$364,270 | ||||||
2024-01-16 | COLL | Dreyer Scott | EVP, Chief Commercial Officer | S - Sale | $32.28 | -23,560 | 111,322 | -17% | -$760,519 | ||||||
| D | 2023-12-21 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale+OE | $30.38 | -4,357 | 275,000 | -2% | -$132,377 | |||||
| DM | 2023-12-18 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale+OE | $30.18 | -68,768 | 275,000 | -20% | -$2,075,086 | |||||
| D | 2023-11-27 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale+OE | $25.78 | -25,600 | 119,518 | -18% | -$660,014 | |||||
2023-06-26 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $21.72 | -17,984 | 119,518 | -13% | -$390,633 | ||||||
| M | 2023-06-01 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale | $21.84 | -62,544 | 275,000 | -19% | -$1,366,182 | |||||
| M | 2023-05-30 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale | $21.88 | -62,543 | 337,544 | -16% | -$1,368,704 | |||||
2023-03-15 | COLL | Tupper Colleen | EVP, CFO | S - Sale | $23.77 | -31,640 | 105,420 | -23% | -$752,165 | ||||||
2023-03-01 | COLL | Dreyer Scott | EVP, Chief Commercial Officer | S - Sale | $26.70 | -13,324 | 134,882 | -9% | -$355,751 | ||||||
2023-02-13 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $26.88 | -21,811 | 137,502 | -14% | -$586,280 | ||||||
| D | 2023-02-13 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale+OE | $26.88 | -11,250 | 400,087 | -3% | -$302,400 | |||||
2023-01-09 | COLL | Dreyer Scott | EVP, Chief Commercial Officer | S - Sale | $27.39 | -17,834 | 102,798 | -15% | -$488,554 | ||||||
| DM | 2022-12-22 | COLL | Heffernan Michael Thomas | Dir | S - Sale+OE | $23.58 | -25,041 | 28,023 | -47% | -$590,451 | |||||
| M | 2022-12-22 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale | $23.67 | -2,461 | 248,750 | -1% | -$58,252 | |||||
| DM | 2022-12-19 | COLL | Heffernan Michael Thomas | Dir | S - Sale+OE | $23.09 | -83,964 | 28,023 | -75% | -$1,939,143 | |||||
| M | 2022-12-19 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale | $23.08 | -17,842 | 251,211 | -7% | -$411,840 | |||||
| DM | 2022-12-12 | COLL | Heffernan Michael Thomas | Dir | S - Sale+OE | $22.14 | -189,607 | 28,023 | -87% | -$4,197,503 | |||||
| DM | 2022-12-01 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale+OE | $22.72 | -131,053 | 269,053 | -33% | -$2,977,401 | |||||
| D | 2022-11-28 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale+OE | $22.00 | -43 | 323,453 | 0% | -$946 | |||||
| D | 2022-11-22 | COLL | Ciaffoni Joseph | Pres, CEO | S - Sale+OE | $22.00 | -65 | 323,453 | 0% | -$1,430 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |